Testing telomere measurement to help diagnose lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study uses a simple blood test to measure telomeres (parts of your DNA) to see if it can help detect lung cancer earlier. Researchers will compare results from people with lung cancer, heavy smokers, and low-risk individuals to improve diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older
- You have a confirmed diagnosis of lung cancer (small cell or non-small cell) and have not yet started treatment (surgery, chemo, or radiation), OR
- You do not have lung cancer but are at high risk (heavy smoker) OR at low risk, with no current suspicion of lung cancer
- No history of other cancers unless you were successfully treated and cancer-free for at least 5 years
- No major surgery in the past week, and no minor surgery or biopsy in the past 48 hours
- No severe kidney or liver disease, active infection in the past 4 weeks, or other conditions that would make study participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood test that looks for multiple signals to find lung cancer early. If you are a smoker or former smoker over 50, this test might help detect cancer before you have symptoms.
This study tests a new chip that may detect lung cancer from a blood sample. It will compare blood from people with lung cancer and people without, possibly helping to find or monitor the disease in the future.
This study uses an AI-powered blood test to identify people at high risk for lung cancer early, before symptoms appear. You'd be helping researchers see if this blood test can catch lung cancer sooner in people with COPD who have a smoking history.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
This study is testing a new blood test that looks for DNA from lung cancer cells in your blood. It aims to see if the test can find lung cancer early, even before symptoms start.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.